Cheng Huang

Capital Medical University

SCHOLARLY PAPERS

2

DOWNLOADS

118

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Dynamic Early Survival Prediction Model for Hepatocellular Carcinoma Patients Treated with Atezolizumab and Bevacizumab: A Longitudinal Deep Learning Analysis

Number of pages: 38 Posted: 21 Feb 2025
Weiming Li, Xiaoqian Xu, Hao Wang, Shun Li, Lichen Shi, Cheng Huang, Hong You, Ji-Dong Jia, Youwen He and Yuanyuan Kong
Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University - Experimental Center, Capital Medical University - Liver Research Center, Duke University and Capital Medical University
Downloads 73 (726,825)

Abstract:

Loading...

Hepatocellular Carcinoma, Survival Prediction Model, Atezolizumab and Bevacizumab, Overall Survival

2.

Identification of Growth Differentiation Factor-15 as an Early Predictive Biomarker for Metabolic Dysfunction-Associated Steatohepatitis: A Nested Case-Control Study of UK Biobank Proteomic Data

Number of pages: 44 Posted: 26 Sep 2024
Hao Wang, Xiaoqian Xu, Lichen Shi, Cheng Huang, Yameng Sun, Hong You, Ji-Dong Jia, You-Wen He and Yuanyuan Kong
Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University - Liver Research Center, Capital Medical University - Liver Research Center, Duke University and Capital Medical University
Downloads 45 (889,715)

Abstract:

Loading...

Metabolic dysfunction-associated steatohepatitis, Metabolic dysfunction-associated steatotic liver disease, Growth differentiation factor 15, Predictive biomarkers, Proteomics